Please login to the form below
Seattle Generics
This page shows the latest Seattle Generics news and features for those working in and with pharma, biotech and healthcare.
Seattle Genetics signs $2bn deal for Immunomedics' cancer drug
Seattle Genetics signs $2bn deal for Immunomedics' cancer drug. Buys rights to breast cancer drug candidate that could be be in line for FDA approval by year end. ... Immunomedics has signed up Seattle Genetics as the licensee for its triple-negative
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
- Business Unit Head, Medical Communications, London
-
Excellent package
- Senior Project Manager - Medical Writing
-
Great salary and bebefits
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
Competitive salary
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Client Services Director - Med Comms
-
Great salary and bebefits
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- NHS England says yes to Roche's Hemlibra
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Moving annual total (MAT)
- Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’
- Roche keeps Venclexta train rolling with new leukaemia filing
- Scratching the surface: unmet needs in psoriasis
- Healthcare Comms news
- Shift to preventative healthcare - Opportunities for screening, diagnostics and vaccination
- Conference Live for ongoing congress performance measurement
- Eyeforpharma Real World Evidence Conference Round up 2018
- GDPR and events. What does the pharma industry need to know?
PMHub
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to...
Latest intelligence
- GDPR and events. What does the pharma industry need to know?
- ...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
- The rise of vertical integration in the US payer landscape
- Is it a solution to addressing the challenges of the value-based marketplace?...
Quick links
Infographics
